Delta-like 1 (Dlk-1), a Novel Marker of Prostate Basal and Candidate Epithelial Stem Cells, is Downregulated by Notch Signalling in Intermediate/transit Amplifying Cells of the Human Prostate
Affiliations
Background: There is a lack of understanding of the processes that regulate differentiation in the prostate.
Objective: To determine localisation, activity, and regulation of cytodifferentiation-modulatory proteins in the human adult prostate.
Design, Settings, And Participants: Eighteen volunteering patients with organ-confined prostate cancer were prospectively enrolled at a single university hospital.
Intervention: All patients underwent radical prostatectomy, and normal/benign tissue was excised and obtained from the transition zone.
Measurements: Expression and activity of Notch-protein family members, including the Notch-homologous protein Delta-like 1 (Dlk-1/Pref1), were investigated immunohistochemically in normal/benign tissue and explant cultures. The effect of the Notch inhibitor L-685,458 on Dlk-1 expression and cell number was investigated in primary cell cultures, and data were analysed with Student t test.
Results And Limitations: Mature luminal cells were found to co-express Notch-1 and its ligand Jagged1, but epithelia in normal/benign tissue showed no active Notch signalling. The basal cell layer, rare candidate epithelial stem cells, and a subpopulation of neuroendocrine cells expressed the differentiation protein Dlk-1. In explant cultures, luminal cells and Jagged1 expression were lost, whereas intermediate cells downregulated Dlk-1 concomitant with Notch-1 upregulation and activation. Notch inhibition in primary cell cultures led to lower cell densities (p<0.001) and suppressed downregulation of Dlk-1. This is a small study; current results need to be confirmed in larger investigations.
Conclusions: We demonstrate that Notch-1 is upregulated in differentiation of prostate epithelia, and that the novel prostate progenitor marker Dlk-1 is downregulated by Notch signalling in intermediate cells. The identification of Dlk-1-expressing candidate stem and neuroendocrine cells suggests a hierarchical relationship.
Nakamura K, Takahashi K, Sakaguchi I, Satoh T, Zhang L, Yanai H Int J Mol Sci. 2025; 25(24.
PMID: 39769389 PMC: 11679542. DOI: 10.3390/ijms252413627.
Balasubramanian I, Bandyopadhyay S, Flores J, Bianchi-Smak J, Lin X, Liu H EMBO J. 2023; 42(21):e113975.
PMID: 37718683 PMC: 10620768. DOI: 10.15252/embj.2023113975.
Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness.
Grassi E, Pietras A J Histochem Cytochem. 2021; 70(1):17-28.
PMID: 34606325 PMC: 8721543. DOI: 10.1369/00221554211048951.
Niche-derived soluble DLK1 promotes glioma growth.
Grassi E, Jeannot P, Pantazopoulou V, Berg T, Pietras A Neoplasia. 2020; 22(12):689-701.
PMID: 33142235 PMC: 7587507. DOI: 10.1016/j.neo.2020.10.005.
scTyper: a comprehensive pipeline for the cell typing analysis of single-cell RNA-seq data.
Choi J, Kim H, Woo H BMC Bioinformatics. 2020; 21(1):342.
PMID: 32753029 PMC: 7430822. DOI: 10.1186/s12859-020-03700-5.